Sunovion Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUNOVION, and what generic alternatives to SUNOVION drugs are available?
SUNOVION has one approved drug.
There are nine US patents protecting SUNOVION drugs.
There are sixty-two patent family members on SUNOVION drugs in twenty-four countries and nineteen supplementary protection certificates in sixteen countries.
Summary for Sunovion
International Patents: | 62 |
US Patents: | 9 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Patent Litigation for Sunovion: | See patent lawsuits for Sunovion |
Drugs and US Patents for Sunovion
Expired US Patents for Sunovion
Paragraph IV (Patent) Challenges for SUNOVION drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg | ➤ Subscribe | 2014-10-28 |
International Patents for Sunovion Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2004017973 | ⤷ Try a Trial |
Hungary | S1400051 | ⤷ Try a Trial |
Japan | 5855670 | ⤷ Try a Trial |
Japan | 6470164 | ⤷ Try a Trial |
Japan | WO2005009999 | ⤷ Try a Trial |
European Patent Office | 1884242 | ⤷ Try a Trial |
Austria | 431147 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sunovion Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1884242 | C01884242/01 | Switzerland | ⤷ Try a Trial | FORMER OWNER: SUMITOMO DAINIPPON PHARMA CO., LTD., JP |
1884242 | 300690 | Netherlands | ⤷ Try a Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CHANGE OF OWNER(S) NAME |
1884242 | 56/2014 | Austria | ⤷ Try a Trial | PRODUCT NAME: LURASIDON, GEGEBENENFALLS IN FORM SEINER FREIEN BASE ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON.; REGISTRATION NO/DATE: EU/1/14/913 20140327 |
1884242 | 122014000092 | Germany | ⤷ Try a Trial | PRODUCT NAME: LURASIDON, INSBESONDERE EINE PHARMAZEUTISCH VERTRAEGLICHE SALZFORM UND IM SPEZIELLEN DAS HYDROCHLORIDSALZ DAVON; REGISTRATION NO/DATE: EU/1/14/913/001-021 20140321 |
1884242 | PA2014034,C1884242 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: LURASIDONUM; REGISTRATION NO/DATE: EU/1/14/913 20140321 |
1884242 | 2014/051 | Ireland | ⤷ Try a Trial | PRODUCT NAME: LURASIDONE, PARTICULARLY A PHARMACEUTICALLY ACCEPTABLE SALT FORM AND ESPECIALLY THE HYDROCHLORIDE SALT THEREOF; REGISTRATION NO/DATE: EU/1/14/913/001-021 20140321 |
1884242 | 92550 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: LURASIDONE, FACULTATIVEMENT SOUS FORME DE SA BASE LIBRE OU DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES. FIRST REGISTRATION: 20140327 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.